The webinar will start with an overview of the ongoing clinical research undertaken to assess potential candidates for COVID-19 treatment. This will be followed by presenting the findings of a systematic literature review undertaken to identify the major factors affecting the cost effectiveness of antivirals for the treatment of pandemic influenza. The key considerations in the development of treatments for COVID-19 will then be summarised, in light of these findings, including considerations around safety, efficacy, costs and pricing.
- To evaluate the current state of clinical research for developing curative treatments for COVID-19
- To summarise the key considerations when developing treatments for pandemic influenza
To assess the potential clinical and economic value of COVID-19 treatments
Victoria Garcia Cardenas, Senior Lecturer University of Technology Sydney. Chair, Pharmacy Practice Research Special Interest Group - Australia
1. Dalia Dawoud, Associate Editor Research in Social and Administrative Pharmacy Pharmacy Practice Research Special Interest Group - UK
2. Syed Shahzad Hasan, Senior Research Fellow/ Senior Lecturer, University of Huddersfield - UK